| Financial Year |
March 31 2023 |
| Monetary Funds |
335,969,061.54 |
| Held-for-trading Financial Assets |
40,053,041.10 |
| Notes Receivable |
11,343,906.59 |
| Accounts Receivable |
292,575,131.61 |
| Advances to Suppliers |
108,504,465.74 |
| Other Receivables |
3,124,198.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
324,860,762.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,530,390.25 |
| Total Current Assets |
1,138,554,551.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
31,760,299.98 |
| Investment Properties |
-- |
| Fixed Assetes |
330,094,503.15 |
| Under-construction Projects |
21,672,012.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
68,952,538.59 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,921,737.52 |
| Deferred Income Tax Assets |
6,933,736.42 |
| Other Non-Current Assets |
27,873,151.21 |
| Sub-Total of Non-Current Assets |
519,509,911.56 |
| Total Assets |
1,658,064,463.02 |
| Short-Term Loans |
206,000,505.97 |
| Trading Financial liabilities |
24,363.89 |
| Notes Payable |
56,902,173.93 |
| Accounts Payable |
216,709,994.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,978,030.97 |
| Taxes Payable |
2,269,909.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,168,724.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
36,624,370.84 |
| Other Current Liabilities |
7,246,373.76 |
| Sub-Total of Current Liabilities |
541,553,319.73 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,631,166.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,918,691.00 |
| Total Liabilities |
561,472,010.73 |
| Paid-In Capital(Or Share Stock) |
140,297,357.00 |
| Capital Surplus |
624,721,510.77 |
| Surplus Reserve |
31,399,139.74 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
301,713,402.18 |
| Minority Stockholder's Interest |
608,754.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,095,983,697.34 |
| Owner's Equity（Stockholder's Equity） |
1,096,592,452.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,658,064,463.02 |
